Abbott’s Ross business
This article was originally published in The Tan Sheet
Executive Summary
Second quarter sales were up 13%, driven by a strong adult nutritionals business. Adult nutritionals posted a 30% increase in sales, including double-digit growth for Ensure and incremental sales from EAS, the firm said. Pediatric sales were roughly flat due to a difficult comparison with the prior year. The firm explained that EAS sales have been lower than expected due to the downward trend in the low carb diet segment...
You may also be interested in...
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.